Impact the pandemic by the new Coronavirus on the consumption profi le of anxiolytics and antidepressants in the Primary Health Care of the Federal District, Brazil

Authors

  • Kaic Leite Meira Escola Superior de Ciências da Saúde, Setor Médico Hospitalar Norte Conjunto A Bloco 01 Edifício Fepecs - Asa Norte, Brasília - DF, 70710-907 http://orcid.org/0000-0002-7165-244X
  • Fernanda Junges de Araújo Secretaria de Estado de Saúde do Distrito Federal, Administração Central (ADMC) – Edifício PO 700 – (1º e 2º andar) Endereço: Setor de Rádio e TV Norte (SRTVN) – 701 Norte – Via W5 Norte, lote D CEP: 70.719-040 http://orcid.org/0000-0001-5879-1632
  • Rafael Cardinali Rodrigues Secretaria de Estado de Saúde do Distrito Federal, Administração Central (ADMC) – Edifício PO 700 – (1º e 2º andar) Endereço: Setor de Rádio e TV Norte (SRTVN) – 701 Norte – Via W5 Norte, lote D CEP: 70.719-040 http://orcid.org/0000-0003-3746-3909

DOI:

https://doi.org/10.14450/2318-9312.v33.e4.a2021.pp363-369

Keywords:

mental health, psychotropic drugs, coronavirus, pharmaceutical services

Abstract

The new Coronavirus pandemic provided an increase in psychosocial vulnerability and the aggravation of preexisting pathologies, such as depression and anxiety. This work aimed to evaluate the impact of the
COVID-19 pandemic on the consumption of anxiolytics and antidepressants at UBS 4 in Recanto das Emas – Distrito Federal through an observational, cross-sectional study that analyzed the consumption of anxiolytics and antidepressants in the period between February and August 2019 and 2020, using the average monthly consumption and the number of visits. In addition, information on sex and age was also verified to draw a profile of consumption of these medications. Of the 7 medications evaluated, all showed an increase in consumption in 2020, this being 181.90%, 124.36%, 325.33%, 125%, 12.80%, 22.18% and 6.45 % for fl uoxetine 20 mg, amitriptyline 25 mg, imipramine 25 mg, clomipramine 75 mg, diazepam 5 mg, clonazepam 2 mg and clonazepam 2.5mg/mL respectively. There was a predominance of females and the population aged between 20 and 59 years as major consumers of these drugs. In general, there was a great
impact on the consumption profiles of psychotropic drugs in the period evaluated.

Author Biographies

Kaic Leite Meira, Escola Superior de Ciências da Saúde, Setor Médico Hospitalar Norte Conjunto A Bloco 01 Edifício Fepecs - Asa Norte, Brasília - DF, 70710-907

Farmacêutico (UFOB), Residente do Programa Mutiprofissional em Saúde da Família e Comunidade da ESCS/SES-DF.

Fernanda Junges de Araújo, Secretaria de Estado de Saúde do Distrito Federal, Administração Central (ADMC) – Edifício PO 700 – (1º e 2º andar) Endereço: Setor de Rádio e TV Norte (SRTVN) – 701 Norte – Via W5 Norte, lote D CEP: 70.719-040

Farmacêutica (UFRGS), Mestre em Ciências Farmacêuticas (UFRGS), Secretaria de Estado de Saúde do Distrito Federal.

Rafael Cardinali Rodrigues, Secretaria de Estado de Saúde do Distrito Federal, Administração Central (ADMC) – Edifício PO 700 – (1º e 2º andar) Endereço: Setor de Rádio e TV Norte (SRTVN) – 701 Norte – Via W5 Norte, lote D CEP: 70.719-040

Farmacêutico (UNB), Mestre em Saúde Coletiva (UNB), Secretaria de Estado de Saúde do Distrito Federal.

Downloads

Published

2021-12-31

How to Cite

Meira, K. L., de Araújo, F. J., & Rodrigues, R. C. (2021). Impact the pandemic by the new Coronavirus on the consumption profi le of anxiolytics and antidepressants in the Primary Health Care of the Federal District, Brazil. Infarma - Pharmaceutical Sciences, 33(4), 363–369. https://doi.org/10.14450/2318-9312.v33.e4.a2021.pp363-369

Issue

Vol. 33 No. 4 (2021)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).